Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects

Inclusion Criteria: * Caucasian males and females, 18 to 65 years old * Body mass index (BMI) 25.0-29.9 kg/m2 * Generally in good health * Normal fasting blood glucose (FBG) 3.9- \<5.6 mmol/L (70- \<100 mg/dL) and glycated hemoglobin HbA1c of 4- \<5.7 % * Readiness to adhere to consumption of test meals and defined restrictions prior to test meals (refer to section 11.8 for details) * Readiness to adhere to habitual lifestyle during the study, in particular to: 1. maintain the same level of physical activity during the study, including non-strenuous transportation to the study visits 2. if smoking, regular smoking at the same level as prior * to the study and no smoking on days of test meals * prior and during the visit * Stable body weight in the last 3 months prior to V1 (≤5% self-reported change) * Stable concomitant medications (if any) for at least last 3 months prior to V1 * Women of child-bearing potential only: 1. negative pregnancy testing (ß-HCG in urine at V1) 2. commitment to use reliable contraception methods Exclusion Criteria: * Known sensitivity to any ingredients / excipients of the IP * Known food allergy (e.g. to cow's milk, eggs, wheat, crustacean, nuts etc.) * Clinically relevant excursions of safety parameters * Digestion/absorption disorders in gastrointestinal (GI) tract (e.g. inflammatory bowel disease) * Uncontrolled hypertension \>140/90 mmHg at V1 * Uncontrolled thyroid disorder at V1 * Any serious condition or disease that renders subjects ineligible * Change in daily dose of any treatment and/or use of supplements with a possible impact on glycemic control in the last 3 months prior to V1 and throughout the study (refer to section 10 for details) * Use of any anti-diabetic treatment or use of treatment and/or supplementation, for reduction of blood glucose levels within the last 4 weeks before V1 and throughout the study * Use of medications or dietary supplements that may influence body weight ≤4 weeks and gastrointestinal functions ≤2 weeks prior to V1 and during the study * Antibiotic and cortisone therapy ≤2 weeks prior to V1 and during the study * Vegetarians and subjects with self-reported diet high in fat or protein * Strenuous exercise within one day prior to each blood glucose sampling (including V1) * History of bariatric surgery, small bowel resection or extensive bowel resection * Recent blood donation within ≤1 month prior to study * Alcohol abuse (men: ≥21 units/week, women: ≥14 units/ week; 1 unit equals approximately 250 mL of beer, 100 mL of wine or 35 mL of spirits) and any alcohol consumption within 24 h before blood glucose sampling * Inability to comply with study procedures * Pregnancy or nursing * Participation in another study during the last 30 days of the screening visit (V1) * Any other reason deemed suitable for exclusion, per investigator's judgment